Rapid Identification of MINOCA Based on Novel Biomarkers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2616 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-05

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Among the patients diagnosed as acute myocardial infarction by coronary angiography, 5%-25% of the patients did not find coronary artery obstructive lesions. These patients do not need PCI. The discovery and verification of clinical protocols for accurate identification of myocardial infarction in the absence of obstructive coronary artery disease（MINOCA）is a major issue that needs to be addressed.Novel biomarkers like grow stimulation expressed gene 2（ST2）can indicate the degree of coronary artery obstruction, copeptin is a biomarker of cardiac emergency state. No clinical studies have been conducted to evaluate whether the novel biomarkers combination regimen can diagnose or exclude MINOCA.

Our research aims to establish and validate a model for the recognition of MINOCA based on novel biomarkers (ST2, copeptin) and to evaluate the prognostic value of novel biomarkers among patients with acute chest pain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Biomarkers of Inflammation and Endothelial Dysfunction in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries

NCT06446895

Myocardial Infarction MINOCA Inflammation +2 more

RECRUITING

Correlational Study on the Biomarkers Application to the Prediction and Diagnosis of Cardiovascular Diseases

NCT02179047

Stable Angina

COMPLETED

Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction

NCT02641184

Coronary Artery Disease Percutaneous Coronary Intervention Acute Myocardial Infarction

UNKNOWN

Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.

NCT00769574

Coronary Syndrome

COMPLETED NA

Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease

NCT02751060

Coronary Disease

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A cross-sectional study design will be used to evaluate the correlation between baseline novel biomarkers（ST2 and copeptin）and MINOCA, and to establish a discriminant model for the identification of MINOCA, and to verify its discriminant efficacy. A cohort study design will be used to evaluate the prognostic role of novel biomarkers in patients with acute chest pain.

On the basis of precision cohort (BIPASS), the project team will adopt the method of cross-sectional diagnostic experimental study design. ①Blood samples of MINOCA and AMI were extracted. According to the new biomarkers（ST2 and copeptin）reported in literature, the team will detect and combine them with troponin, and correct the covariate. And then establish the multivariate joint discriminant model. ②At the same time, according to the propensity score, patients will be selected from UA in a 1:1 matching ratio for modeling. The discriminant model for rapid recognition of MINOCA will be verified by internal cross validation and external validation. Based on this discriminant model, whether the combined application of three biomarkers in MINOCA diagnosis is superior to that of a single biomarker will also be evaluated. Patients with acute chest pain from multi-center will be selected to verify the accuracy of the rapid discriminant model of MINOCA applied to patients with acute chest pain.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Infarction With Non-obstructive Coronary Arteries Grow Stimulation Expressed Gene 2 Copeptin Identification Prognosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

* The clear diagnosis of MINOCA, acute myocardial infarction（AMI) and unstable angina（UA) in BIpass
* The clear diagnosis of MINOCA from the multi-center cohort

Exclusion Criteria

* Prior surgery (cardiac or non-cardiac), trauma or clinically evident coagulopathic bleeding (e.g. gastrointestinal, genitourinary, et al)
* Patient with non-cardiac co-morbidities with life expectancy less than 12 months
* Patients unwilling or unable to comply with all clinical follow-up schedules

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No